{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Nrf2", "oxidative stress", "oxygen", "ozone", "systems medicine"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35283761", "DateRevised": {"Year": "2022", "Month": "03", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "02", "Day": "23"}], "ELocationID": ["842229", "10.3389/fphys.2022.842229"], "Journal": {"ISSN": "1664-042X", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in physiology", "ISOAbbreviation": "Front Physiol"}, "ArticleTitle": "Ozone in Medicine: A Few Points of Reflections.", "Pagination": {"StartPage": "842229", "MedlinePgn": "842229"}, "Abstract": {"AbstractText": ["Notwithstanding the use of ozone in medicine has become widespread in many countries of the world, its real pharmacological action remains not completely clarified. We know that other than its uses as disinfectant, well documented by the literature since the beginning of the past century, the more recent medical use of ozone in several pathologies as described by the international literature is still poor investigated. Furthermore, following its clinical uses with excellent clinical responses on several heterogeneous diseases and pain, it is now clear that the biological activity of this gas is mediated by graded responses to the mild oxidative stress induced after its application. Thus, the ancestral environment of our cells, whose energy production is strictly bind to oxygen burn, may be mediated by common defenses probably linked to the ubiquitous signaling pathway mediated by Nrf2. Moreover, after the first description of the oxidative stress in the 1970s and the discovery of Nrf2 as transcription factor in 1994, we could observe a rapid growth of the literatures regarding its function as master regulator of a myriad of cellular processes and its association to a multiple pattern of diseases including aging. In conclusion, to our opinion, the Systems Medicine approach could finally give to us the real key to better understand the wide reported efficacy of ozone treatment."], "CopyrightInformation": "Copyright \u00a9 2022 Re."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Former Researcher Clinical Pharmacology Department, Marche Polytechnic University, Ancona, Italy."}], "LastName": "Re", "ForeName": "Lamberto", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Physiol", "NlmUniqueID": "101549006", "ISSNLinking": "1664-042X"}, "CoiStatement": "The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "NIH US (2022). Complementary Health Approaches. Available online at: https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name"}, {"Citation": "DHA UAE (2022). Ozone Medical Therapy Clinic. Available online at: https://www.dha.gov.ae/en/DubaicomplementaryMedicineCenter/Pages/Services.aspx"}, {"Citation": "TGA AU (2022). Australian Register of Therapeutic Goods. Available online at: https://search.tga.gov.au/s/search.html?collection=tga-artg&profile=record&meta_i=295329"}, {"Citation": "MSP Cuba (2022). Medicina Natural Y Tradicional. Available online at: https://salud.msp.gob.cu/para-continuar-impulsando-juntos-la-medicina-natural-y-tradicional/"}, {"Citation": "Braun S., Hanselmann C., Gassmann M. G., Born-Berclaz C., Chan K., Kan Y. W., et al. (2002). Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22 5492\u20135505. 10.1128/mcb.22.15.5492-5505.2002", "ArticleIdList": ["10.1128/mcb.22.15.5492-5505.2002", "PMC133949", "12101242"]}, {"Citation": "Cuadrado A., Manda G., Hassan A., Alcaraz M. J., Barbas C., Daiber A., et al. (2018). Transcription FACTOR NRF2 as a therapeutic target for chronic diseases: a systems medicine approach. Pharmacol. Rev. 70 348\u2013383.", "ArticleIdList": ["29507103"]}, {"Citation": "Cuadrado A., Pajares M., Benito C., Jim\u00e9nez-Villegas J., Escoll M., Fern\u00e1ndez-Gin\u00e9s R., et al. (2020). Can activation of NRF2 Be a strategy against COVID-19? Trends Pharmacol. Sci. 41 598\u2013610. 10.1016/j.tips.2020.07.003", "ArticleIdList": ["10.1016/j.tips.2020.07.003", "PMC7359808", "32711925"]}, {"Citation": "Erario M. D. L. \u00c1, Croce E., Moviglia B. M. T., Moviglia G., Grangeat A. M. (2021). Ozone as modulator of resorption and inflammatory response in extruded nucleus pulposus herniation. Revising concepts. Int. J. Mol. Sci. 22:9946. 10.3390/ijms22189946", "ArticleIdList": ["10.3390/ijms22189946", "PMC8469341", "34576108"]}, {"Citation": "Hayes J. D., Dinkova-Kostova A. T. (2014). The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39 199\u2013218. 10.1016/j.tibs.2014.02.002", "ArticleIdList": ["10.1016/j.tibs.2014.02.002", "24647116"]}, {"Citation": "Hybertson B. M., Gao B., Bose S. K., McCord J. M. (2011). Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol. Aspects Med. 32 234\u2013246.", "ArticleIdList": ["22020111"]}, {"Citation": "Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 313\u2013322.", "ArticleIdList": ["9240432"]}, {"Citation": "Kuosmanen S. M., Kansanen E., Kaikkonen M. U., Sihvola V., Pulkkinen K., Jyrkk\u00e4nen H. K., et al. (2018). NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation. Nucleic Acids Res. 46 1124\u20131138. 10.1093/nar/gkx11", "ArticleIdList": ["10.1093/nar/gkx11", "PMC5815049", "29161413"]}, {"Citation": "La Rojo de Vega M., Chapman E., Zhang D. D. (2018). NRF2 and the hallmarks of cancer. Cancer Cell 34 21\u201343. 10.1016/j.ccell.2018.03.022", "ArticleIdList": ["10.1016/j.ccell.2018.03.022", "PMC6039250", "29731393"]}, {"Citation": "Lewis K. N., Mele J., Hayes J. D., Buffenstein R. (2010). Nrf2, a guardian of health span and gatekeeper of species longevity. Integr. Comp. Biol. 50 829\u2013843.", "ArticleIdList": ["PMC2965188", "21031035"]}, {"Citation": "Malhotra D., Portales-Casamar E., Singh A., Srivastava S., Arenillas D., Happel C., et al. (2010). Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network 812 analysis. Nucleic Acids Res. 38 5718\u20135734.", "ArticleIdList": ["PMC2943601", "20460467"]}, {"Citation": "Moi P., Chan K., Asunis I., Cao A., Kan Y. W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 91 9926\u20139930.", "ArticleIdList": ["PMC44930", "7937919"]}, {"Citation": "Re L. (2020). A mild oxidative stress could modulate the Nrf2 pathway in CoVid-19 patients. Japan J. Res. 1 1\u20132."}, {"Citation": "Re L., Mart\u00ednez-S\u00e1nchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M. A., et al. (2014). Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 742 158\u2013162.", "ArticleIdList": ["25218903"]}, {"Citation": "Sagai M., Bocci V. (2011). Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med. Gas Res. 1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Wang X. J., Sun Z., Villeneuve N. F., Zhang S., Zhao F., Li Y., et al. (2008). Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29 1235\u20131243. 10.1093/carcin/bgn095", "ArticleIdList": ["10.1093/carcin/bgn095", "PMC3312612", "18413364"]}, {"Citation": "Xiang M., Feng J., Geng L., Yang Y., Dai C., Li J., et al. (2019). Total oxidant/antioxidant status of sera in lung cancer patients. Medicine (Baltimore) 98:e17179. 10.1097/MD.0000000000017179", "ArticleIdList": ["10.1097/MD.0000000000017179", "PMC6750341", "31517874"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "23"}, {"Year": "2022", "Month": "1", "Day": "13"}, {"Year": "2022", "Month": "3", "Day": "14", "Hour": "5", "Minute": "57"}, {"Year": "2022", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["35283761", "PMC8905360", "10.3389/fphys.2022.842229"]}}], "PubmedBookArticle": []}